Elitech–Bruker: investment, 202312– acquisition €870m in cash of Elitech Group from PAI Partners SIGNED Put Option Letter

	Period	2023-12-23
	Predecessor	Elitech–PAI Partners: investment, 201705– acquisition of Elitech Group by PAI Partners from Ergon Capital Partners
	Money taker	TecInvest S.à.r.l. (d/b/a Elitech Group)
	Today	MabVax Therapeutics Holdings Inc. (Nasdaq: MBVX)
	Group	Elitech (Group)
	Money source	Bruker Invest AG (CH)
	Group	Bruker (Group)
	Product	molecular diagnostics
	Product 2	private equity
	Person	Drago, Stefano (PAI Partners 202312 Partner)
	Source	Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners] CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest eve

Record changed: 2024-01-09

More documents for Elitech (Group)

[1] PAI Partners SAS. (12/27/23). "Press Release: PAI Partners Enters into Agreement for the Sale of ELITech Group to Bruker Corporation"....
[2] Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners] CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest ev...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]